Notably, the population with IDH-1/2 mutations and seizures as first symptoms is quite low, probably due to the fact that the analysis was focused on GBM only; hence, the non-statistical significance could be due to the lack of a proper sample size. Here, IDH1 is linked to glioblastoma.